Bioscience

About Bioscience

Bioscience (Tianjin) Diagnostic Technology Co., Ltd. is a high-tech enterprise established in 2010, specializing in the research, development, manufacturing, and sales of in-vitro diagnostic (IVD) instruments and reagents. The company's main offerings include laboratory automation assembly lines, chemiluminescence immunoassay (CLIA) analyzers, point-of-care testing (POCT) instruments, and a wide range of reagents for detecting infectious diseases, tumor markers, cardiac markers, and more.

Operating from Tianjin, China, the company serves hospitals, independent laboratories, and medical institutions. Its business model integrates R&D, production, and marketing to provide comprehensive diagnostic solutions. The product portfolio features various models of immunoassay analyzers, such as the Axceed series, and POCT analyzers designed for rapid testing of numerous health indicators. During the COVID-19 pandemic, the company developed and received regulatory approval for serological and antigen rapid tests for the virus.

Under the guidance of Academician Chen Hongyuan, the R&D team has secured hundreds of patents and medical device registration certificates. The company has also participated in significant national scientific research projects, including the "863" Program. It has received investments from firms such as Qiming Venture Partners and Sunland Capital.